ribavirin has been researched along with Nephrotic Syndrome in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 10 (83.33) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atsumi, T; Fujieda, Y; Nakai, M; Nakamura, H; Yasuda, S | 1 |
| Iñigo, P; Lasierra, P; Moros, M; Pérez-Calvo, J | 1 |
| El-Nahas, AM; Fox, S; Grabowska, A; Irving, WL; Kudesia, G; Sabry, AA; Sheaashaa, HA; Sobh, MA; Wagner, BE; Wild, G | 1 |
| Abou Ayache, R; Bridoux, F; Goujon, JM; Provôt, F; Touchard, G | 1 |
| Merican, I; Suresh, RL; Suryati, Y | 1 |
| Brouwer, JT; Mathot, RA; Orlent, H; Schalm, SW; Van Bommel, EF; Vulto, AG | 1 |
| Alves Couto, C; Costa Faria, L; de Abreu Ferrari, TC; de Melo Couto, OF; de Paula Farah, K; Dias Ribeiro, D | 1 |
| Buti, M; Esteban, R; Majó, J; Segarra, A; Tovar, JL | 1 |
| Ahmed, MS; Kapoor, N; Pandya, BK; Shawki, H; Wong, CF | 1 |
| Azoulay, D; Charpentier, B; Debuire, B; Ducret, F; Féray, C; Gigou, M; Lemoine, A; Paradis, V; Pham, HP; Samuel, D | 1 |
| Allegri, L; Buzio, C; Carnevali, L; Catellani, W; Garini, G; Manganelli, P | 1 |
| Willson, RA | 1 |
3 review(s) available for ribavirin and Nephrotic Syndrome
| Article | Year |
|---|---|
[Renal damage during type II cryoglobulinemia].
Topics: Acute Disease; Adrenal Cortex Hormones; Antiviral Agents; Biopsy; Cryoglobulinemia; Female; Glomerulonephritis, Membranoproliferative; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-alpha; Kidney; Kidney Diseases; Male; Microscopy, Electron; Middle Aged; Nephritis; Nephrotic Syndrome; Plasma Exchange; Prognosis; Ribavirin | 2003 |
Rapidly deteriorating renal function with membranoproliferative glomerulonephritis Type 1 associated with hepatitis C treated successfully with steroids and antiviral therapy: a case report and review of literature.
Topics: Adult; Anti-Inflammatory Agents; Antiviral Agents; Biopsy; Creatinine; Drug Therapy, Combination; Glomerulonephritis, Membranoproliferative; Glucocorticoids; Hepatitis C; Humans; Immunoglobulin M; Interferon alpha-2; Interferon-alpha; Kidney; Kidney Failure, Chronic; Male; Methylprednisolone; Nephrotic Syndrome; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2008 |
Nephrotoxicity of interferon alfa-ribavirin therapy for chronic hepatitis C.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Middle Aged; Nephrotic Syndrome; Ribavirin | 2002 |
9 other study(ies) available for ribavirin and Nephrotic Syndrome
| Article | Year |
|---|---|
Remission of Nephrotic Syndrome After Therapy for Chronic Hepatitis C Virus Infection in a Patient With Systemic Lupus Erythematosus.
Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Lupus Nephritis; Nephrotic Syndrome; Prednisolone; Remission Induction; Ribavirin; Sofosbuvir; Tacrolimus | 2018 |
Role of ribavirin in membranoproliferative glomerulonephritis associated with hepatitis C virus infection refractory to alpha-interferon.
Topics: Antiviral Agents; Cyclophosphamide; Drug Resistance; Female; Glomerulonephritis, Membranoproliferative; Hepatitis C, Chronic; Humans; Interferon Type I; Middle Aged; Nephrotic Syndrome; Recombinant Proteins; Ribavirin | 2002 |
Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Kidney; Kidney Diseases; Kidney Glomerulus; Liver; Male; Microscopy, Electron; Middle Aged; Nephrotic Syndrome; Recombinant Proteins; Ribavirin; Treatment Outcome | 2002 |
Interferon induced glomerular disease in a patient with chronic hepatitis C.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferons; Liver Function Tests; Male; Nephrotic Syndrome; Ribavirin | 2003 |
Peginterferon and dose-titrated ribavirin for hepatitis C-associated nephrotic membranoproliferative glomerulonephritis type 1.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Nephrotic Syndrome; Polyethylene Glycols; Recombinant Proteins; Renal Insufficiency; Ribavirin | 2005 |
Life-threatening thrombocytopenia and nephrotic syndrome due to focal segmental glomerulosclerosis associated with pegylated interferon alpha-2b and ribavirin treatment for hepatitis C.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Nephrotic Syndrome; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thrombocytopenia | 2006 |
De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infection.
Topics: Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Nephrotic Syndrome; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2008 |
Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients.
Topics: Antiviral Agents; Drug Tolerance; Female; Glomerulonephritis; Hepatitis C; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Nephrotic Syndrome; Recurrence; Ribavirin; Viremia | 1998 |
Interferon-alpha in combination with ribavirin as initial treatment for hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis.
Topics: Adult; Aged; Cryoglobulinemia; Diagnosis, Differential; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Hepatitis C; Humans; Interferon-alpha; Male; Nephrotic Syndrome; Ribavirin; Treatment Outcome | 2001 |